Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-11-06
1992-05-19
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 514 15, 514 16, 530324, 530325, 530326, 530327, 530328, A61K 3702, C07K 706, C07K 708
Patent
active
051149214
ABSTRACT:
Amphiphilic biologically active peptides and intermediates. For example, the polypeptide comprises a chain of at least four groups of four amino acids. In each group of four amino acids, two amino acids are hydrophobic, one amino acid is basic hydrophilic, and the remaining amino acid is basic or neutral hydrophilic. A preferred amino acid sequence is Ala-Phe-Ser-Lys.
REFERENCES:
patent: 4107298 (1978-08-01), Luning
patent: 4617149 (1986-10-01), DiMarchi et al.
patent: 4636489 (1987-01-01), Seemuller et al.
patent: 4659692 (1987-04-01), Lehrer et al.
patent: 4668662 (1987-05-01), Tripier
patent: 4791100 (1988-12-01), Kramer et al.
Mihara, et al, "Design and Synthesis of Basic Amphiphilic Peptides Processing Antimicrobial Activity and Their Interaction with Lipids", Peptide Chemistry (1985), pp. 223-228.
Lee, et al, "Effect of Amphiphilic Model Peptides on Biomembranes and Mast Cells", Peptide Chemistry (1985) pp. 317-320.
Lee Lester L.
The Children's Hospital of Philadelphia
LandOfFree
Amphiphilic peptides and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amphiphilic peptides and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amphiphilic peptides and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2417551